The Community Guide

- gsearch

Search Results

Narrow Results:

2018 19

Journal Article 19

Abstracts 19
Conference Publications 19

1 - 19 of 19 Results

Refine Results

Refine Results:

1723. Mumps Attack Rates Following Administration of a Third Dose of MMR Vaccine to School-Aged Children, Arkansas, 2016–2017

CITE Title : 1723. Mumps Attack Rates Following Administration of a Third Dose of MMR Vaccine to School-Aged Children, Arkansas, 2016–2017 Personal Author(s) : Guo, Angela;Ayers, Tracy;Leung, Jessica;Fields, Virgie;Va, Puthiery;Safi, Haytham;Waters, Catherine;Wheeler, J Gary;Marin, Mona;Patel, Manisha;Routh, Janell;Haselow, Dirk; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S54. URL : https://stacks.cdc.gov/view/cdc/60942 Guo, Angela et al. (2018). 1723. Mumps Attack Rates Following Administration of a Third Dose of MMR Vaccine to School-Aged Children, Arkansas, 2016–2017. 5 Guo, Angela et al. "1723. Mumps Attack Rates Following Administration of a Third Dose of MMR Vaccine to School-Aged Children, Arkansas, 2016–2017" 5 (2018) Guo, Angela et al. "1723. Mumps Attack Rates Following Administration of a Third Dose of MMR Vaccine to School-Aged Children, Arkansas, 2016–2017" vol. 5, 2018 Export RIS Citation Information.

:

Guo, Angela ;

Ayers, Tracy

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S54.

:

BackgroundDuring the 2016–2017 school year, the largest mumps outbreak in the United States since 2006 occurred in Arkansas with nearly 3,000 cases....
2039. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection

CITE Title : 2039. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection Personal Author(s) : Southwick, Karen;Adams, Eleanor H;Greenko, Jane;Ostrowsky, Belinda;Fernandez, Rafael;Patel, Rutvik;Quinn, Monica;Vallabhaneni, Snigdha;Denis, Ronald Jean;Erazo, Richard;Chaturvedi, Sudha;Haley, Valerie B;Leach, Lynn;Zhu, Yan Chun;Giardina, Rosalie;Lutterloh, Emily C;Blog, Debra S; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S594-S595 URL : https://stacks.cdc.gov/view/cdc/77390 Southwick, Karen et al. (2018). 2039. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection. 5 Southwick, Karen et al. "2039. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection" 5 (2018) Southwick, Karen et al. "2039. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection" vol. 5, 2018 Export RIS Citation Information.

:

Southwick, Karen ;

Adams, Eleanor H

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S594-S595

:

BackgroundNew York State (NYS) is experiencing a continuing outbreak of Candida auris, first identified in 2016. Patients who are colonized asymptomat...
1558. Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab

CITE Title : 1558. Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab Personal Author(s) : Crew, Page;McNamara, Lucy;Waldron, Peter;McCulley, Lynda;Jones, S Christopher;Bersoff-Matcha, Susan; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S484-S485. URL : https://stacks.cdc.gov/view/cdc/60920 Crew, Page et al. (2018). 1558. Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab. 5 Crew, Page et al. "1558. Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab" 5 (2018) Crew, Page et al. "1558. Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab" vol. 5, 2018 Export RIS Citation Information.

:

Crew, Page ;

McNamara, Lucy

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S484-S485.

:

BackgroundNon-meningococcal and nongonococcal Neisseria spp. are usually commensal and rarely cause invasive disease in humans. Eculizumab, a terminal...
363. National Burden of Candidemia, United States, 2017

CITE Title : 363. National Burden of Candidemia, United States, 2017 Personal Author(s) : Tsay, Sharon;Williams, Sabrina;Mu, Yi;Epson, Erin;Johnston, Helen;Farley, Monica M;Harrison, Lee H;Vonbank, Brittany;Shrum, Sarah;Dumyati, Ghinwa;Zhang, Alexia;Schaffner, William;Magill, Shelley;Vallabhaneni, Snigdha; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S142-S143 URL : https://stacks.cdc.gov/view/cdc/77391 Tsay, Sharon et al. (2018). 363. National Burden of Candidemia, United States, 2017. 5 Tsay, Sharon et al. "363. National Burden of Candidemia, United States, 2017" 5 (2018) Tsay, Sharon et al. "363. National Burden of Candidemia, United States, 2017" vol. 5, 2018 Export RIS Citation Information.

:

Tsay, Sharon ;

Williams, Sabrina

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S142-S143

:

BackgroundCandidemia is a common healthcare-associated bloodstream infection associated with high morbidity and mortality. No current estimates exist ...
LB11. Rapid Rise in Decreased Susceptibility to Azithromycin among Shigella Isolates in the United States: A Look at National Surveillance Data, 2011–2017

CITE Title : LB11. Rapid Rise in Decreased Susceptibility to Azithromycin among Shigella Isolates in the United States: A Look at National Surveillance Data, 2011–2017 Personal Author(s) : Friedman, Cindy;Plumb, Ian;Reynolds, Jared;Chen, Jessica;Tagg, Kaitlin;Caidi, Hayat;Watkins, Louise Francois;Karp, Beth; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S763. URL : https://stacks.cdc.gov/view/cdc/61209 Friedman, Cindy et al. (2018). LB11. Rapid Rise in Decreased Susceptibility to Azithromycin among Shigella Isolates in the United States: A Look at National Surveillance Data, 2011–2017. 5 Friedman, Cindy et al. "LB11. Rapid Rise in Decreased Susceptibility to Azithromycin among Shigella Isolates in the United States: A Look at National Surveillance Data, 2011–2017" 5 (2018) Friedman, Cindy et al. "LB11. Rapid Rise in Decreased Susceptibility to Azithromycin among Shigella Isolates in the United States: A Look at National Surveillance Data, 2011–2017" vol. 5, 2018 Export RIS Citation Information.

:

Friedman, Cindy ;

Plumb, Ian

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S763.

:

BackgroundShigella spp. cause ~500,000 illnesses in the United States annually. Antibiotics are recommended for immunocompromised patients and shorten...
923. Rapid Emergence of Candida auris in the Chicago Region

CITE Title : 923. Rapid Emergence of Candida auris in the Chicago Region Personal Author(s) : Kerins, Janna L;Tang, Angela S;Forsberg, Kaitlin;Jegede, Olufemi;Ealy, Michelle;Pacilli, Massimo;Welsh, Rory M;Murphy, Elizabeth B;Fealy, Amy;Walters, Maroya Spalding;Raczniak, Gregory;Vallabhaneni, Snigdha;Black, Stephanie R;Kemble, Sarah K; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S28 URL : https://stacks.cdc.gov/view/cdc/77387 Kerins, Janna L et al. (2018). 923. Rapid Emergence of Candida auris in the Chicago Region. 5 Kerins, Janna L et al. "923. Rapid Emergence of Candida auris in the Chicago Region" 5 (2018) Kerins, Janna L et al. "923. Rapid Emergence of Candida auris in the Chicago Region" vol. 5, 2018 Export RIS Citation Information.

:

Kerins, Janna L ;

Tang, Angela S

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S28

:

BackgroundIn 2016, Candida auris was first reported in the United States, with 2 Illinois patients among the first cases. In response, the state and 3...
125. eGISP: Enhanced Surveillance of Neisseria gonorrhoeae Antimicrobial Susceptibility in the United States

CITE Title : 125. eGISP: Enhanced Surveillance of Neisseria gonorrhoeae Antimicrobial Susceptibility in the United States Personal Author(s) : Quilter, Laura;Cyr, Sancta St;Abitria, Vincent;Ancharski, Andrew;Bautista, Ilene;Bazan, Jose;Carifo, Karen;Ervin, Melissa;Harrison, Rebecca;Hoogenboom, Aaron;Peterson, Amy;Pham, Cau;Snyder, Brandon;Turner, Abigail Norris;Torrone, Elizabeth; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S8. URL : https://stacks.cdc.gov/view/cdc/61207 Quilter, Laura et al. (2018). 125. eGISP: Enhanced Surveillance of Neisseria gonorrhoeae Antimicrobial Susceptibility in the United States. 5 Quilter, Laura et al. "125. eGISP: Enhanced Surveillance of Neisseria gonorrhoeae Antimicrobial Susceptibility in the United States" 5 (2018) Quilter, Laura et al. "125. eGISP: Enhanced Surveillance of Neisseria gonorrhoeae Antimicrobial Susceptibility in the United States" vol. 5, 2018 Export RIS Citation Information.

:

Quilter, Laura ;

Cyr, Sancta St

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S8.

:

BackgroundThe Gonococcal Isolate Surveillance Project (GISP), which monitors trends in N. gonorrhoeae susceptibility among men with gonococcal urethri...
284. Antibiotic Usage in the First Year of Life in HIV-Exposed, Uninfected Infants in Malawi: Results From the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study

CITE Title : 284. Antibiotic Usage in the First Year of Life in HIV-Exposed, Uninfected Infants in Malawi: Results From the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study Personal Author(s) : Kourtis, Athena;Ewing, Alexander;Davis, Nicole;Kayira, Dumbani;Hosseinipour, Mina;Horst, Charles Van Der;Jamieson, Denise; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S117. URL : https://stacks.cdc.gov/view/cdc/60923 Kourtis, Athena et al. (2018). 284. Antibiotic Usage in the First Year of Life in HIV-Exposed, Uninfected Infants in Malawi: Results From the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study. 5 Kourtis, Athena et al. "284. Antibiotic Usage in the First Year of Life in HIV-Exposed, Uninfected Infants in Malawi: Results From the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study" 5 (2018) Kourtis, Athena et al. "284. Antibiotic Usage in the First Year of Life in HIV-Exposed, Uninfected Infants in Malawi: Results From the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study" vol. 5, 2018 Export RIS Citation Information.

:

Kourtis, Athena ;

Ewing, Alexander

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S117.

:

BackgroundAntibiotic resistance is a serious health hazard driven by overuse. Antibiotic usage in low-income countries is poorly studied. HIV-exposed,...
1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia

CITE Title : 1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia Personal Author(s) : Zhang, Alexia Y;Shrum, Sarah;Williams, Sabrina;Vonbank, Brittany;Hillis, Sherry;Barter, Devra;Petnic, Sarah;Harrison, Lee H;Dumyati, Ghinwa;Phipps, Erin C;Pierce, Rebecca;Schaffner, William;Farley, Monica M;Mody, Rajal K;Chiller, Tom;Jackson, Brendan R;Vallabhaneni, Snigdha; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S53-S54 URL : https://stacks.cdc.gov/view/cdc/77388 Zhang, Alexia Y et al. (2018). 1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia. 5 Zhang, Alexia Y et al. "1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia" 5 (2018) Zhang, Alexia Y et al. "1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia" vol. 5, 2018 Export RIS Citation Information.

:

Zhang, Alexia Y ;

Shrum, Sarah

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S53-S54

:

BackgroundKnown risk factors for candidemia include diabetes, malignancy, antibiotics, total parenteral nutrition (TPN), prolonged hospitalization, ab...
384. Findings From a Candida auris Admission Screening Pilot in New York State

CITE Title : 384. Findings From a Candida auris Admission Screening Pilot in New York State Personal Author(s) : Dufort, Elizabeth M;Erazo, Richard;Quinn, Monica;Chaturvedi, Sudha;Vallabhaneni, Snigdha;Haley, Valerie B;Lutterloh, Emily;Kuang, Jiankun;Stover, Carolyn;Bucher, Coralie;McDonald, Robert;Adams, Eleanor H;Blog, Debra S; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S148-S149 URL : https://stacks.cdc.gov/view/cdc/77393 Dufort, Elizabeth M et al. (2018). 384. Findings From a Candida auris Admission Screening Pilot in New York State. 5 Dufort, Elizabeth M et al. "384. Findings From a Candida auris Admission Screening Pilot in New York State" 5 (2018) Dufort, Elizabeth M et al. "384. Findings From a Candida auris Admission Screening Pilot in New York State" vol. 5, 2018 Export RIS Citation Information.

:

Dufort, Elizabeth M ;

Erazo, Richard

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S148-S149

:

BackgroundCandida auris is an emerging multidrug-resistant yeast which can spread within healthcare facilities and is associated with significant morb...
2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents

CITE Title : 2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents Personal Author(s) : Myers, Tanya;Weintraub, Eric;McNeil, Michael;Sukumaran, Lakshmi;Duffy, Jonathan;Baxter, Roger;Klein, Nicola P;Daley, Matthew F;Donahue, James;Tseng, Hung Fu;Irving, Stephanie;Jackson, Michael L;Omer, Saad; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S737-S738. URL : https://stacks.cdc.gov/view/cdc/60921 Myers, Tanya et al. (2018). 2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents. 5 Myers, Tanya et al. "2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents" 5 (2018) Myers, Tanya et al. "2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents" vol. 5, 2018 Export RIS Citation Information.

:

Myers, Tanya ;

Weintraub, Eric

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S737-S738.

:

BackgroundThe first quadrivalent meningococcal conjugate vaccine (MenACWY-D) was recommended for use in adolescents in 2005. Soon after, case reports ...
1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility

CITE Title : 1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility Personal Author(s) : Paul, Prabasaj;Forsberg, Kaitlin;Vallabhaneni, Snigdha;Lockhart, Shawn R;Litvintseva, Anastasia P;Kerins, Janna L;Tang, Angela S;Jegede, Olufemi;Barrett, Patricia M;Ross, Kathleen;Slayton, Rachel;Jernigan, John A; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S386-S387 URL : https://stacks.cdc.gov/view/cdc/77389 Paul, Prabasaj et al. (2018). 1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility. 5 Paul, Prabasaj et al. "1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility" 5 (2018) Paul, Prabasaj et al. "1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility" vol. 5, 2018 Export RIS Citation Information.

:

Paul, Prabasaj ;

Forsberg, Kaitlin

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S386-S387

:

BackgroundCandida auris is a multidrug-resistant yeast causing outbreaks in healthcare settings. Stopping the spread of C. auris requires rapid identi...
379. Pediatric Bloodstream Infections by Candida auris in Colombia: Clinical Characteristics and Outcomes of 34 Cases

CITE Title : 379. Pediatric Bloodstream Infections by Candida auris in Colombia: Clinical Characteristics and Outcomes of 34 Cases Personal Author(s) : Berrio, Indira;Caceres, Diego H.;Coronell, R, Wilfrido;Salcedo, Soraya;Mora, Laura;Marin, Adriana;Varón, Carmen;Escandón, Patricia;Rivera, Sandra;Chiller, Tom;Vallabhaneni, Snigdha; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S147 URL : https://stacks.cdc.gov/view/cdc/77392 Berrio, Indira et al. (2018). 379. Pediatric Bloodstream Infections by Candida auris in Colombia: Clinical Characteristics and Outcomes of 34 Cases. 5 Berrio, Indira et al. "379. Pediatric Bloodstream Infections by Candida auris in Colombia: Clinical Characteristics and Outcomes of 34 Cases" 5 (2018) Berrio, Indira et al. "379. Pediatric Bloodstream Infections by Candida auris in Colombia: Clinical Characteristics and Outcomes of 34 Cases" vol. 5, 2018 Export RIS Citation Information.

:

Berrio, Indira ;

Caceres, Diego H.

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S147

:

BackgroundThe emerging multidrug-resistant yeast Candida auris can cause invasive infections associated with high mortality. To date, a majority of C....
385. The Value Added From Candida auris Point Prevalence and Environmental Studies in New York State

CITE Title : 385. The Value Added From Candida auris Point Prevalence and Environmental Studies in New York State Personal Author(s) : Adams, Eleanor H;Quinn, Monica;Ostrowsky, Belinda;Southwick, Karen;Greenko, Jane;Fernandez, Rafael;Patel, Rutvik;Denis, Ronald Jean;Erazo, Richard;Chaturvedi, Sudha;Leach, Lynn;Zhu, Yan Chun;Haley, Valerie B;Tsay, Sharon;Vallabhaneni, Snigdha;Lutterloh, Emily C;Blog, Debra S;Dufort, Elizabeth M; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S149 URL : https://stacks.cdc.gov/view/cdc/77394 Adams, Eleanor H et al. (2018). 385. The Value Added From Candida auris Point Prevalence and Environmental Studies in New York State. 5 Adams, Eleanor H et al. "385. The Value Added From Candida auris Point Prevalence and Environmental Studies in New York State" 5 (2018) Adams, Eleanor H et al. "385. The Value Added From Candida auris Point Prevalence and Environmental Studies in New York State" vol. 5, 2018 Export RIS Citation Information.

:

Adams, Eleanor H ;

Quinn, Monica

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S149

:

BackgroundAs of March 25 2018, 151 clinical cases of C. auris were diagnosed in NYS. We conducted point prevalence surveys (PPS) and environmental sur...
646. Activated Macrophages as Pathogenesis Factors in Ebola Virus Disease in Humans

CITE Title : 646. Activated Macrophages as Pathogenesis Factors in Ebola Virus Disease in Humans Personal Author(s) : McElroy, Anita;Shrivastava-Ranjan, Punya;Harmon, Jessica;Martines, Roosecelis;Silva-Flannery, Luciana;Flietstra, Timothy;Kraft, Colleen;Mehta, Aneesh K;III, G Marshall Lyon;Varkey, Jay;Ribner, Bruce;Nichol, Stuart;Zaki, Sherif;Spiropoulou, Christina; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S234. URL : https://stacks.cdc.gov/view/cdc/60924 McElroy, Anita et al. (2018). 646. Activated Macrophages as Pathogenesis Factors in Ebola Virus Disease in Humans. 5 McElroy, Anita et al. "646. Activated Macrophages as Pathogenesis Factors in Ebola Virus Disease in Humans" 5 (2018) McElroy, Anita et al. "646. Activated Macrophages as Pathogenesis Factors in Ebola Virus Disease in Humans" vol. 5, 2018 Export RIS Citation Information.

:

McElroy, Anita ;

Shrivastava-Ranjan, Punya

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S234.

:

BackgroundEbola virus disease (EVD) is associated with elevated cytokine levels that are more pronounced in fatal cases. This type of hyperinflammator...
966. Infectious Diseases among US Resident Student Travelers after Return to the United States: A GeoSentinel Analysis, 2007–2017

CITE Title : 966. Infectious Diseases among US Resident Student Travelers after Return to the United States: A GeoSentinel Analysis, 2007–2017 Personal Author(s) : Angelo, Kristina M;Haulman, Jean;Terry, Anne;Leung, Daniel;Chen, Lin H;Barnett, Elizabeth;Hagmann, Stefan;Hynes, Noreen;Connor, Bradley;Anderson, Susan;Hamer, Davidson; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S36. URL : https://stacks.cdc.gov/view/cdc/61208 Angelo, Kristina M et al. (2018). 966. Infectious Diseases among US Resident Student Travelers after Return to the United States: A GeoSentinel Analysis, 2007–2017. 5 Angelo, Kristina M et al. "966. Infectious Diseases among US Resident Student Travelers after Return to the United States: A GeoSentinel Analysis, 2007–2017" 5 (2018) Angelo, Kristina M et al. "966. Infectious Diseases among US Resident Student Travelers after Return to the United States: A GeoSentinel Analysis, 2007–2017" vol. 5, 2018 Export RIS Citation Information.

:

Angelo, Kristina M ;

Haulman, Jean

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S36.

:

BackgroundThe number of US students studying abroad has more than tripled over the past 20 years. As study abroad programs diversify their destination...
161. Prevalence and Risk Factors for Candida auris Colonization Among Patients in a Long-term Acute Care Hospital—New Jersey, 2017

CITE Title : 161. Prevalence and Risk Factors for Candida auris Colonization Among Patients in a Long-term Acute Care Hospital—New Jersey, 2017 Personal Author(s) : Rozwadowski, Faye;McAteer, Jarred;Chow, Nancy A;Skrobarcek, Kimberly;Forsberg, Kaitlin;Barrett, Patricia M;Greeley, Rebecca;Fulton, Tara;Wells, Julia;Welsh, Rory M;Dietz, Stephanie;Derado, Gordana;Jackson, Brendan R;Vallabhaneni, Snigdha; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : November 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S14 URL : https://stacks.cdc.gov/view/cdc/77386 Rozwadowski, Faye et al. (2018). 161. Prevalence and Risk Factors for Candida auris Colonization Among Patients in a Long-term Acute Care Hospital—New Jersey, 2017. 5 Rozwadowski, Faye et al. "161. Prevalence and Risk Factors for Candida auris Colonization Among Patients in a Long-term Acute Care Hospital—New Jersey, 2017" 5 (2018) Rozwadowski, Faye et al. "161. Prevalence and Risk Factors for Candida auris Colonization Among Patients in a Long-term Acute Care Hospital—New Jersey, 2017" vol. 5, 2018 Export RIS Citation Information.

:

Rozwadowski, Faye ;

McAteer, Jarred

November 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S14

:

BackgroundCandida auris can be transmitted in healthcare settings, and patients can become asymptomatically colonized, increasing risk for invasive in...
769. An Outbreak of Multidrug-Resistant Tuberculosis, Minnesota 2016–2017

CITE Title : 769. An Outbreak of Multidrug-Resistant Tuberculosis, Minnesota 2016–2017 Personal Author(s) : Desilva, Malini;Moore, Nora;Thai, Dzung;Grimm, Mary Beth;Sabuwala, Nadya;Brueshaber, Milayna;Gordon, Sarah;Andersen, Laura;Hall, Victoria;Buuck, Sean;Hickman, Cynthia;Stinebaugh, Katie;Silk, Benjamin;Raz, Kayla;Talarico, Sarah;Wortham, Jonathan;Kingdon, Elisabeth;Pistulka, Gina;Guerard, Krissie;Cowan, Lauren;Posey, James E;Snippes Vagnone, Paula M;McCullough, Joel;Tsukayama, Dean;Mody, Rajal K;Ehresmann, Kristen; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S276. URL : https://stacks.cdc.gov/view/cdc/60925 Desilva, Malini et al. (2018). 769. An Outbreak of Multidrug-Resistant Tuberculosis, Minnesota 2016–2017. 5 Desilva, Malini et al. "769. An Outbreak of Multidrug-Resistant Tuberculosis, Minnesota 2016–2017" 5 (2018) Desilva, Malini et al. "769. An Outbreak of Multidrug-Resistant Tuberculosis, Minnesota 2016–2017" vol. 5, 2018 Export RIS Citation Information.

:

Desilva, Malini ;

Moore, Nora

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S276.

:

BackgroundMultidrug-resistant tuberculosis (MDR TB) is more difficult to treat and outcomes are worse than for drug-susceptible TB disease. MDR TB cas...
2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017

CITE Title : 2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017 Personal Author(s) : Arana, Jorge;Su, John;Lewis, Paige;Cano, Maria;Markowitz, Lauri E;Shimabukuro, Tom; Conference Author(s) : IDWeek (2018 October 3-7 : San Franciso, CA) Published Date : Nov 26 2018 Source : Open Forum Infect Dis. 2018; 5(Suppl 1):S738. URL : https://stacks.cdc.gov/view/cdc/60922 Arana, Jorge et al. (2018). 2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017. 5 Arana, Jorge et al. "2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017" 5 (2018) Arana, Jorge et al. "2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017" vol. 5, 2018 Export RIS Citation Information.

:

Arana, Jorge ;

Su, John

Nov 26 2018 | Open Forum Infect Dis. 2018; 5(Suppl 1):S738.

:

Background9-valent human papillomavirus vaccine (9vHPV) was licensed in December 2014 and recommended by the Advisory Committee on Immunization Practi...